Rani Therapeutics Holdings, Inc. (RANI)
Last updated: 2026-10-21 23:43:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Rani Therapeutics Holdings, Inc. (RANI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.61, with a market capitalization of $75.06M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.60 to $3.87. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$75.06M | |
$0.66 | |
$36.27 | |
$0.39 | |
$0.65 | |
667.59K | |
631.26K | |
-- | |
$3.87 | |
$0.60 | |
-- | |
-- |
Rani Therapeutics Holdings, Inc. (RANI) After-Hours Stock Price
Rani Therapeutics Holdings, Inc. (RANI) is trading at $0.64 in after-hours trading as of 2026-10-21 23:31:00, down 2.73% ($0.02) from the regular-session close of $0.65.
After-hours trading shows how investors are pricing RANI after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Rani Therapeutics Holdings, Inc. (RANI) 7-Day Stock Price Change
Over the past seven days, Rani Therapeutics Holdings, Inc. (RANI) moved from $0.75 to $0.61, representing a decline of 19.30% ($0.14).
The stock traded between $0.60 and $0.80 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 644.39 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
RANI 52-Week Price Position
Position in Range: 0.1%
RANI is currently trading at $0.61, placing it 0.1% of the way from its 52-week low of $0.60 to its 52-week high of $3.87. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Rani Therapeutics Holdings, Inc. (RANI)?
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Rani Therapeutics Holdings, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 69 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Rani Therapeutics Holdings, Inc. (RANI) Stock on MEXC
Eligible investors can buy real shares of Rani Therapeutics Holdings, Inc. (RANI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Rani Therapeutics Holdings, Inc. (RANI) stock price today?
2.Is RANI stock going up or down today?
3.What is RANI pre-market price?
4.What is RANI after-hours price?
5.Is RANI stock trading now?
6.Where does RANI sit relative to its 52-week high and low?
7.What sector is Rani Therapeutics Holdings, Inc. in?
8.What is Rani Therapeutics Holdings, Inc.'s market capitalization and where is it listed?
9.How is RANI valued in terms of P/E ratio and EPS?
10.Does Rani Therapeutics Holdings, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
RANI Stock Calculator
Estimate the value between RANI shares and USD.
RANI Shares to USD
1.00 RANI shares = 0.606 USD
Calculations are estimates based on the latest available price and are for reference only.


